B. Braun Medical

What B. Braun Medical does

B. Braun Medical Inc. is the U.S. operating subsidiary of the privately held B. Braun Group of Companies, a global medical technology conglomerate headquartered in Germany with operations in 64 countries and more than 64,000 employees worldwide. The U.S. entity is headquartered in Bethlehem, Pennsylvania, employs 8,500 people across more than 30 North American locations, and manufactures pharmaceutical and medical device products including IV solutions, infusion pumps, injectable drugs, vascular access devices, and regional anesthesia products. Core proprietary technologies include the DUPLEX ready-to-activate two-compartment IV container, NRFit small-bore connectors for neuraxial applications, and the only FDA-approved room-temperature-stable prefilled Rocuronium Bromide syringe on the market. The company also maintains specialty brand affiliates (Aesculap Implant Systems, Aesculap Surgical Specialties, B. Braun Interventional Systems, and Central Admixture Pharmacy Services).

Name

B. Braun Medical

Legal name

B. Braun Medical Inc.

Website

https://bbraunusa.com

Company type

Private

Founded year

1839

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

B. Braun Medical Inc. is the U.S. subsidiary of Germany's B. Braun Group, manufacturing IV solutions, infusion pumps, injectable drugs, and regional anesthesia products for hospitals and health systems across North America.

Ownership category

akta.pro rank

Product category

Medical Devices and Pharmaceuticals

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

akta.pro secondary industries

Infusion & Home Infusion Pharmacy Services (HLAFALAG), Generic Hospital & Institutional Products (HLAIABAL), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN), Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ), Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers) (IMALAIAH)

Keywords

• Infusion therapy devices
• IV drug delivery
• Pharmaceutical manufacturing
• Medical device manufacturing
• Regional anesthesia products

Headquarters

HQ city

Bethlehem

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Infrastructure, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of medical devices including IV bags, infusion pumps, needleless products, administration sets, vascular access devices, and regional anesthesia products.
2. Pharmaceutical/Injectable Drug Sales: Sale of FDA-approved injectable pharmaceuticals including antibiotics (Piperacillin/Tazobactam, Cefazolin, Meropenem), anticoagulants (Heparin), and anesthesia drugs (Rocuronium, Midazolam) primarily in premixed, ready-to-use formats.
3. Smart Infusion Therapy Systems: Integrated infusion therapy systems including pumps, software, and associated consumables for hospital and healthcare facility use.
4. Clinical Nutrition Products: Parenteral nutrition solutions and TrophAmine amino acid products for neonatal and clinical nutrition applications.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

B. Braun Medical manufactures and sells medical devices and pharmaceutical products for infusion therapy, pain management, and clinical nutrition. Core offerings include IV solutions and containers, smart infusion pumps, needleless products and administration sets, vascular access devices, ready-to-activate DUPLEX drug delivery systems, premixed injectable drugs (heparin, antibiotics, anesthesia agents), prefilled syringes, NRFit connectors for neuraxial anesthesia, surgical implants (via Aesculap), and pharmacy admixture services (via CAPS). Products are sold to hospitals, health systems, IDNs, dialysis centers, and government healthcare facilities.

Product overview

B. Braun Medical is a medical technology company offering integrated healthcare solutions across multiple platforms. The core product portfolio centers on the DUPLEX Drug Delivery System, a ready-to-activate two-compartment IV container technology that keeps medication and diluent separate until administration, available with various antibiotics including Piperacillin and Tazobactam, Cephalosporins (Cefazolin, Cefoxitin, CefTRIaxONE, Cefepime), Carbapenems (Meropenem), and penicillins. Additional key offerings include the NRFit Connector system for neuraxial and regional anesthesia safety, Smart Infusion Products (IV fluids, irrigation solutions, needleless products, infusion pumps, vascular access), Safe and Efficient Pharmacy solutions (automated compounding, clinical nutrition, pharmacy admixture), a comprehensive Heparin Sodium Injection portfolio (largest premixed offering in U.S.), and Renal Therapies including dialysis care and training. The company emphasizes patient and environmental safety through DEHP-free and PVC-free products including CARESAFE IV Administration Sets, EXCEL IV Containers, and TrophAmine Neonatal products. Specialty brands include Aesculap (Implants, Surgical Specialties), B. Braun Interventional Systems, and Central Admixture Pharmacy Services (CAPS). The company also offers the Supply Assurance Program for supply chain resiliency.

Differentiator

Problem solved

Functional benefit

Brands

• DUPLEX Drug Delivery System: Ready-to-activate, two-compartment IV container system that keeps pre-measured medication and diluent separate until administration, designed to simplify drug preparation and reduce medication errors.
• NRFit Connectors
• CARESAFE IV Administration Sets
• EXCEL IV Containers

Products and services

• DUPLEX Drug Delivery System Ready-to-activate, two-compartment IV container that keeps pre-measured medication and diluent separate until mixing and administration. Closed-system design prevents contamination, reduces medication errors, and eliminates the need for syringes and vials. Targets hospitals and health systems for IV drug preparation.
• NRFit Connectors Small-bbore connectors designed to prevent misconnections in neuraxial and regional anesthesia applications. Yellow NRFit connectors enable quick identification of regional anesthesia catheters to mitigate cross-connections and improve patient safety. Targets hospitals and surgical centers performing regional anesthesia procedures.
• Piperacillin and Tazobactam in DUPLEX Container Antibiotic combination (penicillin-class beta-lactam and beta-lactamase inhibitor) packaged in the DUPLEX two-chamber IV container. Available in 2.25 g/50 mL, 3.375 g/50 mL, and 4.5 g/100 mL dosages. Room temperature storage with bedside activation. Targets hospital pharmacy and inpatient antibiotic therapy.
• Cephalosporins in DUPLEX Container Portfolio of cephalosporin antibiotics in DUPLEX containers covering four generations, including Cefazolin (1g, 2g, 3g), Cefoxitin (1g, 2g), CefTRIaxONE (1g, 2g), and Cefepime (1g, 2g). Not made with DEHP, PVC, or natural rubber latex. Targets hospital pharmacy and inpatient antibiotic therapy.
• Carbapenems in DUPLEX Container Meropenem for Injection USP in DUPLEX two-compartment IV container. Available in 500 mg and 1 g dosages. Not made with PVC, DEHP, or natural rubber latex. Protects healthcare workers from exposure to airborne cephalosporins. Targets hospital pharmacy and inpatient antibiotic therapy.
• Heparin Sodium Injection Portfolio Largest offering of Heparin Premixed bags in the U.S. market (seven products). Includes Heparin Sodium 25,000 Units in 0.45% Sodium Chloride Injection at 50 units/mL and 100 units/mL concentrations. Manufactured in EXCEL IV Containers not made with DEHP, PVC, or natural rubber latex, with 2D enhanced barcode including NDC, lot number, and expiration date. Targets hospitals, dialysis centers, and health systems for anticoagulation therapy.
• Rocuronium Bromide Injection Prefilled Syringe First and only FDA-approved room-temperature-stable Rocuronium Bromide Injection in a prefilled syringe. Single-dose 50 mg/5 mL Luer lock syringe, preservative-free, with 24-month shelf life and no refrigeration required. Targets hospitals, surgical centers, and anesthesia providers for neuromuscular blockade.
• Midazolam in 0.8% Sodium Chloride Injection Sedative/anxiolytic medication with preservative-free formulation featuring barcode technology and packaging free of DEHP, PVC, and latex. Targets hospitals and surgical centers for procedural sedation and anesthesia induction.
• CARESAFE IV Administration Sets First robust portfolio of IV administration sets in the U.S. not made with DEHP or PVC. Part of B. Braun's commitment to eliminating toxic chemicals from IV products to protect patients and the environment. Targets hospitals and health systems for IV medication administration.
• EXCEL IV Containers IV containers manufactured using polypropylene and not made with DEHP, PVC, or natural rubber latex. Used for heparin products and other injectable solutions. Supports patient and environmental safety. Targets hospitals and healthcare facilities requiring DEHP-free IV containers.
• TrophAmine Amino Acids and Neonatal Starter Bags Specialized neonatal nutritional products not made with DEHP or PVC. Designed for vulnerable neonatal patient populations who may rely on IVs for extended periods. Targets NICU and pediatric hospital units.
• Smart Infusion Products Comprehensive smart infusion therapy portfolio including IV fluids and irrigation solutions, needleless products and administration sets, smart infusion pumps, and vascular access products designed for integrated infusion therapy delivery. Targets hospitals and health systems.
• Safe and Efficient Pharmacy Products Pharmacy solutions including automated compounding and clinical nutrition solutions, pharmacy admixture devices, and premium convenience products (DUPLEX system) for streamlined drug preparation and administration. Targets hospital pharmacies and pharmacy compounding operations.
• Renal Therapies Renal care offerings including dialysis care services and renal training programs for healthcare professionals. Targets dialysis centers and renal care providers.
• Surgical Procedures Products Surgical product offerings including regional anesthesia and acute pain management solutions featuring NRFit connectors. Targets hospitals, surgical centers, and anesthesia departments.
• Aesculap Implant Systems Wholly-owned subsidiary offering surgical implant systems for surgical applications. Targets hospitals, surgical centers, and orthopedic surgeons.
• Aesculap Surgical Specialties Wholly-owned subsidiary offering surgical specialty products and services. Targets hospitals, surgical centers, and specialty surgeons.
• B. Braun Interventional Systems (BIS) Wholly-owned core operating subsidiary offering interventional medical devices and systems. Targets hospitals and interventional cardiology/radiology departments.
• Central Admixture Pharmacy Services (CAPS) Wholly-owned core operating subsidiary offering pharmacy admixture services for compounded medications. Targets hospital pharmacies requiring outsourced sterile compounding services.

Quantifiable outcome

• 54% fewer process steps vs. traditional compounding
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Three partnerships are on record, tiered minor and core.

• B. Braun Sheffield Sharks and B. Braun Sheffield HattersminorGTM or Marketing Partner · 12 February 2026Sports sponsorship partnership extended until 2030, originally began with men's team in 2008 and expanded to women's team in 2023. Partnership funds the B. Healthy community programme which has driven 15% participation increase at satellite clubs and 59% rise in female engagement across South Yorkshire schools.
• GEDSA (Global Engineered Device Supplier Association)coreStrategic or Co-development PartnerB. Braun is a member of GEDSA, a nonprofit trade association dedicated to advancing patient safety. B. Braun works with the International Organization for Standardization (ISO) to help develop standards for small-bore connectors that focus on neuraxial and regional anesthesia applications.
• India National Pharmaceutical Pricing Authority (NPPA)minorOthersRegulatory body that revised ceiling prices for Meropenem and IV fluids in India, impacting B. Braun India operations alongside Baxter India, Fresenius Kabi, and Otsaka Pharmaceutical India.

Scale indicators8 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Baxter International: Headquartered in Deerfield, IL; Baxter is B. Braun Medical's closest direct competitor in IV bags, IV solutions, and infusion therapy, and competes head-to-head in the global IV bag market (B. Braun's 14% share is alongside Baxter). Comparable product breadth across IV fluids, administration sets, and injectable pharmaceuticals.
• ICU Medical: San Clemente, CA-based; ICU Medical directly competes with B. Braun Medical in IV therapy products, infusion pumps, and needle-free connectors. Also acquired Smiths Medical in early 2025, expanding infusion and pain management overlap. Highly comparable business model and product portfolio.
• Fresenius Kabi: Bad Homburg, Germany-based global player in generic injectable pharmaceuticals and infusion therapy; competes with B. Braun across Heparin, antibiotics, and IV fluids, particularly in Europe and emerging markets. Comparable cross-therapeutic injectable portfolio and infusion products.
• Terumo Corporation: Tokyo, Japan-based global medical device company; competes directly with B. Braun Medical in IV bags, syringes, and infusion therapy systems as one of the four global IV bag market leaders alongside B. Braun. Similar product category breadth in infusion and injection devices.
• Nipro Corporation: Osaka, Japan-based; Nipro manufactures IV bags, infusion sets, dialysis products, and medical devices that directly overlap with B. Braun Medical's infusion and renal therapy portfolios. Strong presence in dialysis adjacent to B. Braun's Renal Therapies business.
• Smiths Medical (ICU Medical): Now part of ICU Medical following 2025 acquisition; historically a direct peer in infusion devices and pain management products including regional anesthesia — both of which overlap with B. Braun's NRFit connector and infusion therapy franchises.
• Vygon: Écouen, France-based privately held medical device company specializing in IV therapy, neonatal/pediatric products, and regional anesthesia — directly comparable to B. Braun Medical's infusion, NICU, and pain management portfolios. Significant overlap in European hospital markets.

Broad incumbents

• Becton Dickinson (BD): Franklin Lakes, NJ-based global medtech incumbent; competes with B. Braun Medical in injection/infusion devices (BD Nexiva, BD Medical) and in injectable drug delivery (BD Pharmaceutical Systems). Larger and broader portfolio but overlapping in the IV/injectable categories where B. Braun competes.
• Pfizer (Hospital Injectables / ex-Hospira): Pfizer's Hospital Injectables portfolio (built on the Hospira acquisition) competes with B. Braun's specialty and generic injectable business across Heparin, antibiotics, and anesthesia drugs. Pharmaceutical-scope overlap rather than device overlap.
• Stryker: Kalamazoo, MI-based large medtech incumbent; competes broadly with B. Braun in surgical specialties, regional anesthesia, and operating-room products including B. Braun's Aesculap franchises. Less direct overlap in IV solutions but overlapping in surgical and anesthesia categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bbraun_de
• Facebookfacebook.com/bbraungroup

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about B. Braun Medical